Related Experiment Video
Updated: Jun 19, 2026

Modifying Levels of Maternal Dietary Folic Acid or Choline to Study the Impact of Deficiencies on Offspring Health Outcomes
Published on: June 28, 2024
Risks of routine iron and folic acid supplementation for young children
S Pasricha1, A Shet, H P S Sachdev
1St Johns Research Institute, St Johns National Academy of Health Sciences, Bangalore, India.
Insights
Routine iron-folic acid (IFA) supplementation for young children in India may increase malaria risk. Recommendations are being revised for malaria-endemic areas, balancing anemia treatment with infection prevention.
Area of Science:
- Pediatric Nutrition
- Public Health Policy
- Infectious Disease Epidemiology
Background:
- Iron-folic acid (IFA) supplementation is recommended for nearly 70% of anemic young children in India.
- A potential risk associated with routine IFA supplementation is an increased incidence of infectious diseases, particularly malaria.
Purpose of the Study:
- To review the evidence on iron-folic acid (IFA) supplementation in children under 5.
- To inform updated recommendations for IFA supplementation policies in India, considering malaria endemicity.
Main Methods:
- Conducted an extensive literature search across PubMed, WHO, and Indian Government databases.
- Focused on studies concerning IFA supplementation in children under 5 years of age.
Main Results:
- Previous reviews indicated potential adverse effects of IFA in malaria-endemic areas.
- A recent trial in Tanzania showed increased malaria-related mortality with IFA, while a Nepal study found no adverse effects in a non-malarious region.
- These findings led the World Health Organization to revise IFA supplementation guidelines for malaria-endemic regions.
Conclusions:
- India exhibits varied malaria endemicity across regions.
- Routine IFA supplementation should continue in non-malarious areas without modification.
- In malarious regions, IFA supplementation should be implemented cautiously, contingent upon effective malaria control and functioning primary healthcare infrastructure.
Context:
Almost 70% of young children in India are anemic. Current policy recommends routine iron-folic acid (IFA) supplementation to all under 5 children. A potential risk of this approach is an increase in infectious diseases in general, and malaria in particular.
Evidence Acquisition:
An extensive literature search including PubMed, the World Health Organization (WHO) document library, and the Indian Government database, for documents regarding IFA supplementation in under-5 children.
Results:
Previously, systematic reviews had suggested adverse effects of IFA supplementation in malaria endemic settings. However, a recent large trial in Tanzania has found clear evidence of increased mortality, chiefly due to malaria, among children receiving routine IFA, whilst a simultaneous study in Nepal (a non-malarious region) found no adverse effects on morbidity or mortality from infectious disease attributable to IFA. These findings have prompted the World Health Organization to revise recommendations regarding IFA supplementation in malaria endemic areas.
Conclusions:
India has a non-homogenous distribution of malaria endemicity. We propose that although no change to IFA supplementation be made in non-malarious regions, routine IFA should be provided in malarious regions once malaria control and primary health care infrastructure are functioning well.
More Related Videos
Related Concept Videos
Vitamins
Drug Dosing: Infants and Children
Teratogenicity
Drug Toxicity: Risk factors
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Factors Affecting Drug Response: Overview

